Clinical Trials
2 trialsNCT07624487 2026-06-03
A Phase II Study of Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
Taipei Medical University Hospital
Phase 2 Not yet recruiting
NCT07482605 2026-03-20
Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion
Jiangmen Central Hospital
Phase 2 Not yet recruiting